Yoda Pharmaceuticals Inc. (TPEX:7829)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
45.30
0.00 (0.00%)
At close: Apr 28, 2026
9.16%
Market Cap 3.60B
Revenue (ttm) n/a
Net Income (ttm) -407.22M
Shares Out 79.39M
EPS (ttm) -5.14
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 54,458
Average Volume 140,731
Open 45.30
Previous Close 45.30
Day's Range 44.50 - 45.35
52-Week Range 32.65 - 77.60
Beta n/a
RSI 43.56
Earnings Date Apr 29, 2026

About Yoda Pharmaceuticals

Yoda Pharmaceuticals Inc., an AI-driven company, focuses on development of drugs targeting central nervous system disorders. The company’s flagship drug, YA-101 is in Phase 2 clinical trial for the treatment of multiple system atrophy. It is also involved in the development pipeline includes drugs in the field of neurological and psychiatric disorders and cerebrovascular diseases, targeting conditions, such as schizophrenia, Alzheimer's disease, Parkinson‘s disease, Autism, ischemic stroke, and traumatic brain injury. Yoda Pharmaceuticals Inc. ... [Read more]

Industry Pharmaceutical Preparations
Founded 2019
Country Cayman Islands
Stock Exchange Taipei Exchange
Ticker Symbol 7829
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.